These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 32698567)

  • 41. Direct Oral Anticoagulant Plasma Levels for the Management of Acute Ischemic Stroke.
    Marsch A; Macha K; Siedler G; Breuer L; Strasser EF; Engelhorn T; Dörfler A; Schwab S; Kallmünzer B
    Cerebrovasc Dis; 2019; 48(1-2):17-25. PubMed ID: 31484174
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The impact of direct oral anticoagulants in traumatic brain injury patients greater than 60-years-old.
    Prexl O; Bruckbauer M; Voelckel W; Grottke O; Ponschab M; Maegele M; Schöchl H
    Scand J Trauma Resusc Emerg Med; 2018 Mar; 26(1):20. PubMed ID: 29580268
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Periprocedural anticoagulation during left atrial ablation: interrupted and uninterrupted vitamin K-antagonists or uninterrupted novel anticoagulants.
    Brinkmeier-Theofanopoulou M; Tzamalis P; Wehrkamp-Richter S; Radzewitz A; Merkel M; Schymik G; van Mark G; Bramlage P; Schmitt C; Luik A
    BMC Cardiovasc Disord; 2018 Apr; 18(1):71. PubMed ID: 29703158
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Outcomes of upper gastrointestinal bleeding are similar between direct oral anticoagulants and vitamin K antagonists.
    Gouriou C; Bouguen G; Lahmek P; Pelaquier A; Arotcarena R; Garioud A; De Montigny-Lenhardt S; Pauwels A; Zanditenas D; Charpignon C; Combes R; Nahon S; Quentin V
    Aliment Pharmacol Ther; 2021 Mar; 53(6):688-695. PubMed ID: 33400827
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Managing direct oral anticoagulants in patients undergoing dentoalveolar surgery.
    Patel JP; Woolcombe SA; Patel RK; Obisesan O; Roberts LN; Bryant C; Arya R
    Br Dent J; 2017 Feb; 222(4):245-249. PubMed ID: 28232717
    [TBL] [Abstract][Full Text] [Related]  

  • 46. World workshop on oral medicine VII: Direct anticoagulant agents management for invasive oral procedures: A systematic review and meta-analysis.
    Manfredi M; Dave B; Percudani D; Christoforou J; Karasneh J; Diz Dios P; Glick M; Kumar N; Lockhart PB; Patton LL
    Oral Dis; 2019 Jun; 25 Suppl 1():157-173. PubMed ID: 31140701
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Four-year cross-sectional study of bleeding risk in dental patients on direct oral anticoagulants.
    Zeevi I; Allon DM; Rosenfeld E; Avishai G; Gilman L; Nissan J; Chaushu G
    Quintessence Int; 2017; 48(6):503-509. PubMed ID: 28439571
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Direct oral anticoagulants versus vitamin K antagonists in real-world patients with nonvalvular atrial fibrillation. The FANTASIIA study.
    Anguita Sánchez M; Bertomeu Martínez V; Ruiz Ortiz M; Cequier Fillat Á; Roldán Rabadán I; Muñiz García J; Badimón Maestro L; Esteve Pastor MA; Marín Ortuño F;
    Rev Esp Cardiol (Engl Ed); 2020 Jan; 73(1):14-20. PubMed ID: 31160265
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Contemporary Management of Direct Oral Anticoagulants During Cardioversion and Ablation for Nonvalvular Atrial Fibrillation.
    Trujillo TC; Dobesh PP; Crossley GH; Finks SW
    Pharmacotherapy; 2019 Jan; 39(1):94-108. PubMed ID: 30548542
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Patients with non-valvular atrial fibrillation on vitamin k antagonists or direct-acting oral anticoagulants: patients profile and long-term follow up outcomes.
    Sigismondi A; Camacho-Freire SJ; León-Jiménez J; Isasti-Aizpurva G; García-Lizana MD; Morgado-García de Polavieja JI; Caro-Fernández FJ; Roa-Garrido J; Navarro-Roldán F; Díaz-Fernández JF
    Arch Cardiol Mex; 2019; 89(4):382-392. PubMed ID: 31834326
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development of a tool to identify patients' preference for vitamin K antagonist or direct oral anticoagulant therapy.
    Zolfaghari S; Harenberg J; Froelich L; Wehling M; Weiss C
    Semin Thromb Hemost; 2014 Feb; 40(1):121-8. PubMed ID: 24381153
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Direct Oral Anticoagulant Treatment and Mild Traumatic Brain Injury: Risk of Early and Delayed Bleeding and the Severity of Injuries Compared with Vitamin K Antagonists.
    Turcato G; Zannoni M; Zaboli A; Zorzi E; Ricci G; Pfeifer N; Maccagnani A; Tenci A; Bonora A
    J Emerg Med; 2019 Dec; 57(6):817-824. PubMed ID: 31648805
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Case-fatality of recurrent venous thromboembolism and major bleeding associated with aspirin, warfarin, and direct oral anticoagulants for secondary prevention.
    Wu C; Alotaibi GS; Alsaleh K; Linkins LA; McMurtry MS
    Thromb Res; 2015 Feb; 135(2):243-8. PubMed ID: 25488466
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Predictors of oral cavity bleeding and clinical outcome after dental procedures in patients on vitamin K antagonists. A cohort study.
    Biedermann JS; Rademacher WMH; Hazendonk HCAM; van Diermen DE; Leebeek FWG; Rozema FR; Kruip MJHA
    Thromb Haemost; 2017 Jun; 117(7):1432-1439. PubMed ID: 28405671
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Perioperative management of oral anticoagulated patients undergoing an oral, implant, or periodontal procedure: a survey of practices of members of two dental scientific societies, the PRADICO study.
    Radoï L; Hajage D; Giboin C; Maman L; Monnet-Corti V; Descroix V; Mahé I
    Clin Oral Investig; 2019 Dec; 23(12):4311-4323. PubMed ID: 30887189
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Management of anticoagulated patients in dentoalveolar surgery: a clinical comparative study.
    Schmitt CM; Rusche B; Clemm R; Neukam FW; Buchbender M
    Clin Oral Investig; 2020 Aug; 24(8):2653-2662. PubMed ID: 31713746
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risk of Cardiovascular Events and Mortality Among Elderly Patients With Reduced GFR Receiving Direct Oral Anticoagulants.
    Ashley J; McArthur E; Bota S; Harel Z; Battistella M; Molnar AO; Jun M; Badve SV; Garg AX; Manuel D; Tanuseputro P; Wells P; Mavrakanas T; Rhodes E; Sood MM
    Am J Kidney Dis; 2020 Sep; 76(3):311-320. PubMed ID: 32333946
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Stroke severity in patients with preceding direct oral anticoagulant therapy as compared to vitamin K antagonists.
    Auer E; Frey S; Kaesmacher J; Hakim A; Seiffge DJ; Goeldlin M; Arnold M; Fischer U; Jung S; Meinel TR
    J Neurol; 2019 Sep; 266(9):2263-2272. PubMed ID: 31165232
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Periprocedural management of patients receiving a vitamin K antagonist or a direct oral anticoagulant requiring an elective procedure or surgery.
    Spyropoulos AC; Al-Badri A; Sherwood MW; Douketis JD
    J Thromb Haemost; 2016 May; 14(5):875-85. PubMed ID: 26988871
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reversal agents for oral anticoagulant-associated major or life-threatening bleeding.
    Moia M; Squizzato A
    Intern Emerg Med; 2019 Nov; 14(8):1233-1239. PubMed ID: 31446606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.